NJ High Court To Review Reversal Of $25M Accutane Verdict
The New Jersey Supreme Court will review an appellate court's decision to toss a jury's $25 million award to a man who claimed Hoffmann-LaRoche Inc.'s acne drug Accutane caused him to...To view the full article, register now.
Already a subscriber? Click here to view full article